Shingo Matsumoto

13.9k total citations · 1 hit paper
437 papers, 10.1k citations indexed

About

Shingo Matsumoto is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Shingo Matsumoto has authored 437 papers receiving a total of 10.1k indexed citations (citations by other indexed papers that have themselves been cited), including 151 papers in Pulmonary and Respiratory Medicine, 109 papers in Oncology and 90 papers in Molecular Biology. Recurrent topics in Shingo Matsumoto's work include Lung Cancer Treatments and Mutations (123 papers), Electron Spin Resonance Studies (67 papers) and Advanced MRI Techniques and Applications (53 papers). Shingo Matsumoto is often cited by papers focused on Lung Cancer Treatments and Mutations (123 papers), Electron Spin Resonance Studies (67 papers) and Advanced MRI Techniques and Applications (53 papers). Shingo Matsumoto collaborates with scholars based in Japan, United States and United Kingdom. Shingo Matsumoto's co-authors include Murali C. Krishna, Kōichi Goto, Kiyotaka Yoh, James B. Mitchell, Tomohito Arao, Fuminori Hyodo, Akira Kawasaki, Koji Baba, Katsuya Tsuchihara and Keita Saito and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Shingo Matsumoto

414 papers receiving 9.9k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cannabidiol Attenuates Cardiac Dysfunction, Oxidative Stress, Fibrosis, and Inflammatory and Cell Death Signaling Pathways in Diabetic Cardiomyopathy

2010 416 citations Keita Saito, Shingo Matsumoto et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shingo Matsumoto Japan	51	2.6k	2.4k	2.3k	1.5k	1.4k	437	10.1k
Jean‐Luc Ravanat France	64	7.9k 3.1×	908 0.4×	1.7k 0.7×	2.1k 1.4×	479 0.3×	181	13.6k
Terry D. Oberley United States	64	6.5k 2.5×	1.3k 0.6×	1.1k 0.5×	1.5k 1.0×	355 0.3×	218	15.0k
Peggy L. Olive Canada	60	8.0k 3.1×	2.7k 1.2×	1.7k 0.7×	6.4k 4.3×	364 0.3×	179	15.6k
Francis L. Martin United Kingdom	58	3.7k 1.4×	504 0.2×	624 0.3×	1.1k 0.8×	5.0k 3.7×	363	13.4k
Shosuke Kawanishi Japan	72	6.7k 2.6×	2.1k 0.9×	1.1k 0.5×	2.4k 1.6×	377 0.3×	301	15.7k
Keith A. Houck United States	58	8.2k 3.2×	1.9k 0.8×	890 0.4×	3.0k 2.0×	251 0.2×	111	17.0k
Yulia Y. Tyurina United States	68	7.7k 3.0×	630 0.3×	2.1k 0.9×	1.5k 1.0×	460 0.3×	206	14.0k
Willem H. Koppenol Switzerland	63	7.4k 2.9×	977 0.4×	871 0.4×	2.0k 1.3×	1.6k 1.1×	213	21.3k
Xianglin Shi United States	77	7.8k 3.0×	1.8k 0.8×	1.4k 0.6×	2.8k 1.9×	197 0.1×	311	19.8k
Shao Hui Huang Canada	50	3.3k 1.3×	2.2k 0.9×	2.1k 0.9×	1.3k 0.9×	609 0.4×	290	11.0k

Countries citing papers authored by Shingo Matsumoto

Since Specialization

Citations

This map shows the geographic impact of Shingo Matsumoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shingo Matsumoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shingo Matsumoto more than expected).

Fields of papers citing papers by Shingo Matsumoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shingo Matsumoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shingo Matsumoto. The network helps show where Shingo Matsumoto may publish in the future.

Co-authorship network of co-authors of Shingo Matsumoto

This figure shows the co-authorship network connecting the top 25 collaborators of Shingo Matsumoto. A scholar is included among the top collaborators of Shingo Matsumoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shingo Matsumoto. Shingo Matsumoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Miyamoto‐Mikami, Eri, Mika Saito, Shingo Matsumoto, et al.. (2025). Association of the GALNTL6 polymorphism with muscle strength in Japanese athletes. Biology of Sport. 42(3). 161–167.

Taki, Tetsuro, Naoya Sakamoto, Shingo Sakashita, et al.. (2024). NETosis in pulmonary pleomorphic carcinoma. Cancer Science. 116(2). 524–532.

Kitagawa, Shingo, Yoshitaka Zenke, Kiyotaka Yoh, et al.. (2023). 236TiP Large-scale prospective observational study to develop a liquid-based detection system of minimal residual disease (MRD): LC-SCRUM-MRD. Annals of Oncology. 34. S275–S276. 1 indexed citations

Kuroda, Shunsuke, Shingo Matsumoto, Takeshi Kitai, et al.. (2022). Assessment of thromboembolism risk in COVID-19 patients with cardiovascular disease risk factors: Analysis of a Japanese Nationwide Registry. Thrombosis Research. 216. 90–96.

Iwama, Eiji, Yoshitaka Zenke, Shunichi Sugawara, et al.. (2021). Trastuzumab emtansine for patients with non–small cell lung cancer positive for human epidermal growth factor receptor 2 exon-20 insertion mutations. European Journal of Cancer. 162. 99–106. 52 indexed citations

Yasui, Hironobu, et al.. (2021). Redox-Sensitive Mapping of a Mouse Tumor Model Using Sparse Projection Sampling of Electron Paramagnetic Resonance. Antioxidants and Redox Signaling. 36(1-3). 57–69. 8 indexed citations

Sahashi, Yuki, Hirohisa Endo, Tadafumi Sugimoto, et al.. (2021). Worries and concerns among healthcare workers during the coronavirus 2019 pandemic: A web-based cross-sectional survey. Humanities and Social Sciences Communications. 8(1). 26 indexed citations

Stewart, Neil J., et al.. (2019). Simultaneous T2* mapping of 14N- and 15N-labeled dicarboxy-PROXYLs using CW-EPR-based single-point imaging. Journal of Magnetic Resonance. 305. 122–130. 8 indexed citations

Makinoshima, Hideki, Shigeki Umemura, Ayako Suzuki, et al.. (2018). Metabolic Determinants of Sensitivity to Phosphatidylinositol 3-Kinase Pathway Inhibitor in Small-Cell Lung Carcinoma. Cancer Research. 78(9). 2179–2190. 33 indexed citations

10.

Matsumoto, Shingo, Shun Kishimoto, Keita Saito, et al.. (2018). Metabolic and Physiologic Imaging Biomarkers of the Tumor Microenvironment Predict Treatment Outcome with Radiation or a Hypoxia-Activated Prodrug in Mice. Cancer Research. 78(14). 3783–3792. 34 indexed citations

11.

Saito, Keita, Kazutoshi Yamamoto, Shingo Matsumoto, et al.. (2018). Synthesis and evaluation of 13C-labeled 5-5-dimethyl-1-pyrroline-N-oxide aimed at in vivo detection of reactive oxygen species using hyperpolarized 13C-MRI. Free Radical Biology and Medicine. 131. 18–26. 10 indexed citations

12.

Takakusagi, Yoichi, Shun Kishimoto, Sarwat Naz, et al.. (2017). Radiotherapy Synergizes with the Hypoxia-Activated Prodrug Evofosfamide: In Vitro and In Vivo Studies. Antioxidants and Redox Signaling. 28(2). 131–140. 27 indexed citations

13.

Nukaga, Shigenari, Hiroyuki Yasuda, Katsuya Tsuchihara, et al.. (2017). Amplification of EGFR Wild-Type Alleles in Non–Small Cell Lung Cancer Cells Confers Acquired Resistance to Mutation-Selective EGFR Tyrosine Kinase Inhibitors. Cancer Research. 77(8). 2078–2089. 131 indexed citations

14.

Miyoshi, Tomohiro, Shigeki Umemura, Yuki Matsumura, et al.. (2016). Genomic Profiling of Large-Cell Neuroendocrine Carcinoma of the Lung. Clinical Cancer Research. 23(3). 757–765. 139 indexed citations

15.

Yoshida, Tatsuya, Genichiro Ishii, Kōichi Goto, et al.. (2014). Podoplanin-Positive Cancer-Associated Fibroblasts in the Tumor Microenvironment Induce Primary Resistance to EGFR-TKIs in Lung Adenocarcinoma with EGFR Mutation. Clinical Cancer Research. 21(3). 642–651. 102 indexed citations

16.

Matsumoto, Shingo, Sonny Batra, Keita Saito, et al.. (2011). Antiangiogenic Agent Sunitinib Transiently Increases Tumor Oxygenation and Suppresses Cycling Hypoxia. Cancer Research. 71(20). 6350–6359. 102 indexed citations

17.

Yasui, Hironobu, Shingo Matsumoto, Nallathamby Devasahayam, et al.. (2010). Low-Field Magnetic Resonance Imaging to Visualize Chronic and Cycling Hypoxia in Tumor-Bearing Mice. Cancer Research. 70(16). 6427–6436. 105 indexed citations

18.

Nakanishi, Hirofumi, Shingo Matsumoto, Reika Iwakawa, et al.. (2009). Whole Genome Comparison of Allelic Imbalance between Noninvasive and Invasive Small-Sized Lung Adenocarcinomas. Cancer Research. 69(4). 1615–1623. 31 indexed citations

19.

Utsumi, Hideo, et al.. (2002). [41] Nitroxyl probes for brain research and their application to brain imaging. Methods in enzymology on CD-ROM/Methods in enzymology. 352. 494–506. 19 indexed citations

20.

Matsumoto, Shingo, et al.. (2000). Effect of application of different plant residues to paddy field on CH4 and CO2 formation process.. 71(2). 210–215. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact